Brazilian Pharmaceutical Diplomacy: Social Democratic Principles versus Soft Power Interests

Current debates concerning the rise of health diplomacy are polarized between competing international relations theories of realism, based on power politics, and constructivist approaches, which emphasize the norms, values, and identities shaping foreign policies. A case study of Brazil's health diplomacy over the past 10 years, focusing on issues related to pharmaceuticals, seeks to provide data to assess these theories. The country's intellectual property disputes, multilateral lobbying efforts, and foreign assistance programs are contrasted with those of the United States, Mexico, and other countries. Instead of viewing Brazilian efforts as a form of soft power, the evidence suggests that the origins of Brazil's involvement and continued efforts in this arena stem more from values based on human rights and social democratic principles. A close examination of domestic political considerations leads to a more nuanced understanding of the drivers behind a country's health diplomacy.

[1]  Peter J. Katzenstein.  The Culture of National Security , 2013 .

[2]  P. Buss.  Global health and health diplomacy. , 2013, Cadernos de saude publica.

[3]  Kelley Lee,et al.  Brazil's ascendance: The soft power role of global health diplomacy , 2011 .

[4]  R. Labonté,et al.  Framing health and foreign policy: lessons for global health diplomacy , 2010, Globalization and health.

[5]  D. Kerrigan.  The politics and history of AIDS treatment in Brazil , 2010 .

[6]  Kerri-Ann Jones.  New Complexities and Approaches to Global Health Diplomacy: View from the U.S. Department of State , 2010, PLoS medicine.

[7]  J. Michaud,et al.  Health diplomacy and the enduring relevance of foreign policy interests. , 2010, PLoS medicine.

[8]  J. Michaud,et al.  Global Health and Foreign Policy , 2010, Epidemiologic reviews.

[9]  T. Novotny,et al.  Brazil and the Framework Convention on Tobacco Control: Global Health Diplomacy as Soft Power , 2010, PLoS medicine.

[10]  Jennifer Prah Ruger,et al.  Emerging and Transitioning Countries’ Role in Global Health , 2010, Saint Louis University journal of health law & policy.

[11]  Charles McManis.  The Proposed Anti-Counterfeiting Trade Agreement (ACTA): Two Tales of a Treaty , 2009 .

[12]  Kenneth C. Shadlen.  The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies , 2009 .

[13]  S. Gruskin,et al.  Changing global essential medicines norms to improve access to AIDS treatment: Lessons from Brazil , 2009, Global public health.

[14]  Thailand,et al.  Oslo Ministerial Declaration—global health: a pressing foreign policy issue of our time , 2007 .

[15]  R. Horton.  Health as an instrument of foreign policy , 2007, The Lancet.

[16]  I. Kickbusch,et al.  Global health diplomacy: training across disciplines. , 2007, Bulletin of the World Health Organization.

[17]  H. Hogerzeil,et al.  Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts? , 2006, The Lancet.

[18]  M. Hirst,et al.  Brazil as an intermediate state and regional power: action, choice and responsibilities , 2006 .

[19]  P. Hunt.  Report of the Special Rapporteur on the Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health, Paul Hunt , 2005 .

[20]  M. A. Oliveira,et al.  Intellectual property in the context of the WTO TRIPS agreement: challenges for public health , 2004 .

[21]  D. Mcneill,et al.  Global Institutions and Development: Framing the World? , 2003 .

[22]  A. Attaran,et al.  Patent Rights and Local Working Under the WTO TRIPS Agreement: An Analysis of the U.S.-Brazil Patent Dispute , 2002 .

[23]  C. Travassos,et al.  Health Sector Reform in Brazil: A Case Study of Inequity , 2000, International journal of health services : planning, administration, evaluation.

[24]  Andy Stelman,et al.  Representative? , 1986 .